Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.040
0.00 (0.00%)
Jun 18, 2026, 3:33 PM HKT
Market Cap1.57B -10.9%
Revenue (ttm)1.37B +16.1%
Net Income238.11M -62.1%
EPS0.16 -62.7%
Shares Out 1.51B
PE Ratio6.68
Forward PEn/a
Dividend0.06 (6.06%)
Ex-Dividend DateMay 27, 2026
Volume296,300
Open1.020
Previous Close1.040
Day's Range1.000 - 1.040
52-Week Range1.000 - 1.470
Beta0.22
AnalystsStrong Buy
Price Target2.69 (+158.65%)
Earnings DateMar 27, 2026

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines for various therapeutic areas, such as cardiovascular syst... [Read more]

Sector Healthcare
Founded 1995
Employees 1,081
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2348
Full Company Profile

Financial Performance

In 2025, HKG:2348's revenue was 1.23 billion, an increase of 16.09% compared to the previous year's 1.06 billion. Earnings were 213.97 million, a decrease of -62.13%.

Financial numbers in CNY Financial Statements